These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23798567)

  • 1. Dmdmdx/Largemyd: a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies.
    Martins PC; Ayub-Guerrieri D; Martins-Bach AB; Onofre-Oliveira P; Malheiros JM; Tannus A; de Sousa PL; Carlier PG; Vainzof M
    Dis Model Mech; 2013 Sep; 6(5):1167-74. PubMed ID: 23798567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models for genetic neuromuscular diseases.
    Vainzof M; Ayub-Guerrieri D; Onofre PC; Martins PC; Lopes VF; Zilberztajn D; Maia LS; Sell K; Yamamoto LU
    J Mol Neurosci; 2008 Mar; 34(3):241-8. PubMed ID: 18202836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of brain dystrophins absence and impact in dystrophin-deficient Dmdmdx rat model.
    Caudal D; François V; Lafoux A; Ledevin M; Anegon I; Le Guiner C; Larcher T; Huchet C
    PLoS One; 2020; 15(3):e0230083. PubMed ID: 32160266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
    Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B
    FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice.
    Liu Y; Yan X; Sun Z; Chen B; Han Q; Li J; Zhao RC
    Stem Cells Dev; 2007 Oct; 16(5):695-706. PubMed ID: 17999592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
    Li D; Long C; Yue Y; Duan D
    Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative transcriptome analysis of muscular dystrophy models Large(myd), Dmd(mdx)/Large(myd) and Dmd(mdx): what makes them different?
    Almeida CF; Martins PC; Vainzof M
    Eur J Hum Genet; 2016 Aug; 24(9):1301-9. PubMed ID: 26932192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
    Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
    Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
    van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
    FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
    Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
    Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative T2 combined with texture analysis of nuclear magnetic resonance images identify different degrees of muscle involvement in three mouse models of muscle dystrophy: mdx, Largemyd and mdx/Largemyd.
    Martins-Bach AB; Malheiros J; Matot B; Martins PC; Almeida CF; Caldeira W; Ribeiro AF; Loureiro de Sousa P; Azzabou N; Tannús A; Carlier PG; Vainzof M
    PLoS One; 2015; 10(2):e0117835. PubMed ID: 25710816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.
    Miller G; Moore CJ; Terry R; La Riviere T; Mitchell A; Piggott R; Dear TN; Wells DJ; Winder SJ
    Hum Mol Genet; 2012 Oct; 21(20):4508-20. PubMed ID: 22810924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene.
    Koppanati BM; Li J; Reay DP; Wang B; Daood M; Zheng H; Xiao X; Watchko JF; Clemens PR
    Gene Ther; 2010 Nov; 17(11):1355-62. PubMed ID: 20535217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.